SCHEMBL23601679

SCHEMBL23601679

C[Si](C)(C)CCOCn1c(=O)c2ccccc2n2cnnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.48
TDO2 P48775 1/20 0.40
PLK1 P53350 5/20 0.37
GAA P10253 4/20 0.37
APOBEC3G Q9HC16 3/20 0.37
EGFR P00533 1/20 0.35
IGF1R P08069 1/20 0.35
SRC P12931 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
EPHB4 P54760 1/20 0.35
TEK Q02763 1/20 0.35
MAPK8 P45983 1/20 0.34
TP53 P04637 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
TSHR P16473 2/20 0.33
ALOX15 P16050 1/20 0.33
CREBBP Q92793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29909038 0.84 NPC1 (0.41) NPC1SMN1; SMN2PLK1MAPK8TP53
SCHEMBL29909221 0.84 NPC1 (0.41) NPC1SMN1; SMN2TDO2PLK1MAPT
SCHEMBL23576856 0.84 NPC1 (0.41) NPC1SMN1; SMN2TDO2PLK1MAPT
SCHEMBL23577631 0.84 NPC1 (0.41) NPC1SMN1; SMN2PLK1MAPK8TP53
SCHEMBL23577842 0.81 NPC1 (0.39) NPC1SMN1; SMN2GAAKDRTDP1
SCHEMBL29909739 0.81 NPC1 (0.39) NPC1SMN1; SMN2GAAKDRTDP1
SCHEMBL29520454 0.72 NPC1 (0.52) NPC1SMN1; SMN2GAAEGFRIGF1R
SCHEMBL7415598 0.70 ALDH1A1 (0.57) SMN1; SMN2PLK1TP53TSHRALDH1A1
SCHEMBL6719104 0.69 NPC1 (0.53) NPC1EGFRIGF1RSRCFLT4
SCHEMBL23576960 0.68 NPC1 (0.49) NPC1SMN1; SMN2TP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-10-13 US disclosed
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK NPC1 991/4885SMN1; SMN2 4737/4885TDO2 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.